These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17032285)

  • 41. Impact of acid inhibition on esophageal mucosal injury induced by low-dose aspirin.
    Sugimoto M; Nishino M; Kodaira C; Yamade M; Uotani T; Ikuma M; Furuta T
    Digestion; 2012; 85(1):9-17. PubMed ID: 22122999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review article: the opportunities and benefits of extended acid suppression.
    Scarpignato C; Pelosini I
    Aliment Pharmacol Ther; 2006 Jun; 23 Suppl 2():23-34. PubMed ID: 16700900
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics and Pharmacodynamics of Azeloprazole Sodium, a Novel Proton Pump Inhibitor, in Healthy Japanese Volunteers.
    Toda R; Shiramoto M; Komai E; Yoshii K; Hirayama M; Kawabata Y
    J Clin Pharmacol; 2018 Apr; 58(4):425-433. PubMed ID: 29193126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined analysis of three crossover clinical pharmacology studies of effects of rabeprazole and esomeprazole on 24-h intragastric pH in healthy volunteers.
    Norris V; Baisley K; Dunn K; Warrington S; Morocutti A
    Aliment Pharmacol Ther; 2007 Feb; 25(4):501-10. PubMed ID: 17270006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the early effects of vonoprazan, lansoprazole and famotidine on intragastric pH: a three-way crossover study.
    Ohkuma K; Iida H; Inoh Y; Kanoshima K; Ohkubo H; Nonaka T; Fujita K; Kusakabe A; Inamori M; Nakajima A
    J Clin Biochem Nutr; 2018 Jul; 63(1):80-83. PubMed ID: 30087548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics, Pharmacodynamics and Safety of Multiple-Infusion Ilaprazole in Healthy Chinese Subjects.
    Wang H; Lang L; Ou N; Shi R; Hu H; Hu P; Jiang J
    Clin Drug Investig; 2016 Jun; 36(6):463-70. PubMed ID: 27067231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early dinner reduces nocturnal gastric acidity.
    Duroux P; Bauerfeind P; Emde C; Koelz HR; Blum AL
    Gut; 1989 Aug; 30(8):1063-7. PubMed ID: 2767502
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early effect on intragastric pH of oral administration of rabeprazole with mosapride compared with rabeprazole alone.
    Iida H; Kaai M; Inoh Y; Kanoshima K; Ohkuma K; Nonaka T; Fujita K; Ida T; Kusakabe A; Maeda S; Nakajima A; Inamori M
    Ann Gastroenterol; 2017; 30(4):424-428. PubMed ID: 28655978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics and pharmacodynamics of intravenous ilaprazole in healthy subjects after single ascending doses.
    Wang H; Ou N; Lang L; Shi R; Hu P; Jiang J
    Xenobiotica; 2016 Dec; 46(12):1133-1141. PubMed ID: 26998954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The timing of the evening meal affects the pattern of 24-hour intragastric acidity.
    Lanzon-Miller S; Pounder RE; McIsaac RL; Wood JR
    Aliment Pharmacol Ther; 1990 Oct; 4(5):547-53. PubMed ID: 2129642
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of gastric acidity by short-duration intragastric pH-monitoring with standardised breakfast in functional and some other dyspepsias.
    Melashchenko S
    Prz Gastroenterol; 2020; 15(3):258-266. PubMed ID: 33005273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The acidity of the tumor microenvironment is a mechanism of immune escape that can be overcome by proton pump inhibitors.
    Bellone M; Calcinotto A; Filipazzi P; De Milito A; Fais S; Rivoltini L
    Oncoimmunology; 2013 Jan; 2(1):e22058. PubMed ID: 23483769
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Proton pump inhibitors reduce the size and acidity of the gastric Acid pocket.
    Jo YJ
    J Neurogastroenterol Motil; 2015 Jan; 21(1):133-4. PubMed ID: 25611065
    [No Abstract]   [Full Text] [Related]  

  • 54. Proton pump inhibitors could inhibit calcium absorption and weaken women's bones.
    Nurs Stand; 2012 Feb; 26(26):15. PubMed ID: 28091215
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Administration of proton pump inhibitors in patients requiring enteral nutrition.
    Wensel TM
    P T; 2009 Mar; 34(3):143-60. PubMed ID: 19561850
    [No Abstract]   [Full Text] [Related]  

  • 56. The final word on proton pump inhibitors and osteoporosis?
    Gerson LB
    Gastroenterology; 2013 Mar; 144(3):650-2. PubMed ID: 23380947
    [No Abstract]   [Full Text] [Related]  

  • 57. Proton Pump Inhibitors In South Africa: Role Of Branded Generics.
    Truter I
    Value Health; 2014 Nov; 17(7):A364. PubMed ID: 27200753
    [No Abstract]   [Full Text] [Related]  

  • 58. Continued Questions About Whether Avoidance of Proton Pump Inhibitors Can Reduce Risk of Dementia.
    Atri A; Gerson LB
    Gastroenterology; 2016 Sep; 151(3):555-8. PubMed ID: 27479443
    [No Abstract]   [Full Text] [Related]  

  • 59. Anti-inflammatory and anti-oxidative properties of proton pump inhibitors.
    Naito Y
    J Clin Biochem Nutr; 2007 Sep; 41(2):82-3. PubMed ID: 18193100
    [No Abstract]   [Full Text] [Related]  

  • 60. Proton Pump Inhibitors.
    Lichtenstein GR
    Gastroenterol Hepatol (N Y); 2018 Mar; 14(3):135. PubMed ID: 29928158
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.